ISRG

Intuitive Surgical, Inc.

NMS · Healthcare

$427.64

$3.68 (+0.87%)up 0.87%

13 October 2026 · delayed 15+ min

D

Quality score63.9 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Intuitive Surgical, Inc. earns a D on excellent profit margins (>20%) and strong current ratio (>2.0) but low Sharpe ratio (0.27) and high P/E ratio (49.5) - may be overvalued. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 3.4% · $340.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 3.4% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-ISRG-20261013engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

Lowest analyst target

$324.00

52-week low

$328.57

Today's price

$427.64

Mean analyst target

$478.10

52-week high

$603.88

Highest analyst target

$685.00

ISRG trades 36% of the way up its 52-week range, between $328.57 and $603.88. The mean analyst target of $478.10 is 11.8% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong current ratio (>2.0) 100.023%

Profit margin

28.45%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

33.60%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

66.68%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

17.42%

Profit per unit of shareholder capital

strongWhat this means

Profit generated per unit of shareholder capital.

Above 15% is generally considered a good business.

Return on assets

10.51%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Current ratio

4.96

Short-term assets over short-term debts

very liquidWhat this means

Short-term assets against short-term obligations.

Plenty of cover, though idle cash earns little.

Quick ratio

3.64

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

18.50%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

26.50%

Year on year

strongWhat this means

Change in earnings against the same period last year.

Profit is compounding at a good clip.

Revenue

$5.66B

Trailing twelve months

Free cash flow

$2.62B

Cash left after capital spending

Operating cash flow

$3.71B

Cash from the business itself

Payout ratio

0.00%

Dividends as a share of earnings

noneWhat this means

The share of earnings paid out as dividends.

All earnings are retained in the business.

Growth & momentumLow Sharpe ratio (0.27) 40.022%

Return, 1 month

13.15%

Return, 3 months

9.94%

Return, 6 months

-8.47%

Return, year to date

-23.90%

Return, 1 year

-0.45%

Return, 3 years

44.63%

Sharpe ratio

0.27

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

52.51%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.05%

Best day

14.27%

Worst day

-14.34%

ValuationHigh P/E ratio (49.5) - may be overvalued; High P/B ratio (8.33) 5.018%

P/E ratio

49.50

Price against trailing earnings

very highWhat this means

You pay 49.50 for every 1 unit of annual earnings.

Above 40 the price assumes growth that then has to actually arrive.

Forward P/E

35.32

Price against forecast earnings

highWhat this means

Price against next year's *forecast* earnings.

Even next year's expected earnings do not bring the multiple down much.

PEG ratio

1.97

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

8.33

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

13.69

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

34.92

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

$145.99B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

353,278,038

Shares the profit is split across

Dividend yield

0.00%

Annual dividend against price

noneWhat this means

Annual dividend as a percentage of the share price.

This company returns cash by reinvesting or buying back shares instead.

TechnicalRSI in healthy range (30-70); MACD bullish (positive histogram) 100.015%

RSI (14)

68.2

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

10.37

Momentum against its own trend

MACD histogram

2.03

Positive is bullish

ADX

14.5

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$403.13

50-day average

$387.58

200-day average

$442.66

Price vs 50-day

10.33%

Price vs 200-day

-3.39%

Bollinger upper

$428.90

Bollinger lower

$377.36

Average true range

11.19

Typical daily trading range

Stochastic %K

95.9

Risk4 measured figures 60.012%

Volatility, annualised

34.58%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

1.46

Moves against the wider market

more volatile than the marketWhat this means

How much the price moves relative to the wider market.

Amplifies the index — bigger gains, bigger falls.

Maximum drawdown

-49.90%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Strong analyst coverage (30 analysts) 90.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

30

Mean price target

$478.10

Highest target

$685.00

Lowest target

$324.00

Implied upside

11.80%

Target against today's price

meaningfulWhat this means

How far the mean analyst target sits above today's price.

Analysts see real room above today's price.

Price against the S&P 500

180 trading days to 2026-10-12

ISRG is 19.1% down over the window, against 12.3% up for the S&P 500 — behind by 31.5 points.
ISRG -19.1%S&P 500 +12.3%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-26, so they can be compared directly.
DateCloseISRG rebasedS&P 500 rebased
2026-01-26$528.81100.0100.0
2026-02-17$493.3593.398.5
2026-03-10$485.8591.997.6
2026-03-31$460.9987.293.9
2026-04-22$483.6291.5102.7
2026-05-13$432.2781.7107.1
2026-06-04$418.8279.2109.1
2026-06-26$404.7076.5105.8
2026-07-20$353.1766.8107.1
2026-08-10$393.3874.4111.6
2026-08-31$376.8671.3110.6
2026-09-22$402.0976.0111.7

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health100.023%23.0
Growth & momentum40.022%8.8
Valuation5.018%0.9
Technical100.015%15.0
Risk60.012%7.2
Analyst view90.010%9.0
ESG50.00%0.0
Quality score100%63.9

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

D

63.9 / 100

Identical to the IQInvest grade.

All 65 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Analysts coveringAnalyst view30Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Highest targetAnalyst view$685.00Yahoo Finance
Implied upsideAnalyst view11.80%Yahoo Finance
Lowest targetAnalyst view$324.00Yahoo Finance
Mean price targetAnalyst view$478.10Yahoo Finance
Current ratioFinancial health4.96Yahoo Finance
Earnings growthFinancial health26.50%Yahoo Finance
Free cash flowFinancial health$2.62BYahoo Finance
Gross marginFinancial health66.68%Yahoo Finance
Operating cash flowFinancial health$3.71BYahoo Finance
Operating marginFinancial health33.60%Yahoo Finance
Payout ratioFinancial health0.00%Yahoo Finance
Profit marginFinancial health28.45%Yahoo Finance
Quick ratioFinancial health3.64Yahoo Finance
Return on assetsFinancial health10.51%Yahoo Finance
Return on equityFinancial health17.42%Yahoo Finance
RevenueFinancial health$5.66BYahoo Finance
Revenue growthFinancial health18.50%Yahoo Finance
Average daily returnGrowth & momentum0.05%Yahoo Finance
Best dayGrowth & momentum14.27%Yahoo Finance
Return, 1 monthGrowth & momentum13.15%Yahoo Finance
Return, 1 yearGrowth & momentum-0.45%Yahoo Finance
Return, 3 monthsGrowth & momentum9.94%Yahoo Finance
Return, 3 yearsGrowth & momentum44.63%Yahoo Finance
Return, 6 monthsGrowth & momentum-8.47%Yahoo Finance
Return, year to dateGrowth & momentum-23.90%Yahoo Finance
Sharpe ratioGrowth & momentum0.27Yahoo Finance
Win rateGrowth & momentum52.51%Yahoo Finance
Worst dayGrowth & momentum-14.34%Yahoo Finance
52-week highMarket data$603.88Yahoo Finance
52-week lowMarket data$328.57Yahoo Finance
Average volumeMarket data2,920,229Yahoo Finance
Day highMarket data$429.27Yahoo Finance
Day lowMarket data$421.03Yahoo Finance
EmployeesMarket data17,021Yahoo Finance
OpenMarket data$423.02Yahoo Finance
Previous closeMarket data$423.96Yahoo Finance
VolumeMarket data1,598,028Yahoo Finance
BetaRisk1.46Yahoo Finance
Maximum drawdownRisk-49.90%Yahoo Finance
Risk categoryRiskHighYahoo Finance
Volatility, annualisedRisk34.58%Yahoo Finance
20-day averageTechnical$403.13Yahoo Finance
200-day averageTechnical$442.66Yahoo Finance
50-day averageTechnical$387.58Yahoo Finance
ADXTechnical14.5Yahoo Finance
Average true rangeTechnical11.19Yahoo Finance
Bollinger lowerTechnical$377.36Yahoo Finance
Bollinger upperTechnical$428.90Yahoo Finance
MACDTechnical10.37Yahoo Finance
MACD histogramTechnical2.03Yahoo Finance
Price vs 200-dayTechnical-3.39%Yahoo Finance
Price vs 50-dayTechnical10.33%Yahoo Finance
RSI (14)Technical68.2Yahoo Finance
Stochastic %KTechnical95.9Yahoo Finance
Dividend yieldValuation0.00%Yahoo Finance
Enterprise valueValuation$145.99BYahoo Finance
EV / EBITDAValuation34.92Yahoo Finance
Forward P/EValuation35.32Yahoo Finance
P/E ratioValuation49.50Yahoo Finance
PEG ratioValuation1.97Yahoo Finance
Price to bookValuation8.33Yahoo Finance
Price to salesValuation13.69Yahoo Finance
Shares outstandingValuation353,278,038Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more